HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
ADMA
Adma Biologics Inc
Healthcare Biotechnology · New Jersey, USA · Reports in usd
Market Cap: $2.26B
Market Cap
$2.26B
Enterprise Val
$2.32B
P/E Ratio
13.39
P/B Ratio
5.54
Trailing PEG (1Y)
0.62
As Of
Aug 19, 2026

Overview & Key Metrics

Reporting period: Jun 30, 2026 · Q2 2026
Book Value$408.2M
Gross Margin69.36%
Profit Margin69.36%
Return on Equity39.59%
Return on Assets26.58%
Current Ratio6.97
Debt/Equity0.48
LT Debt/Equity0.47
Revenue Per Share0.54

Income Statement

Jun 30, 2026
Revenue$124.4M
Cost of Revenue$38.1M
Gross Profit$86.3M
R&D$6.0M
SG&A$26.7M
Operating Expenses$33.8M
Operating Income$52.4M
Interest Expense$3.4M
Tax Expense$12.4M
Net Income$37.8M
EPS (Basic)$0.17
EPS (Diluted)$0.16
EBIT$53.7M
EBITDA$55.4M
Consolidated Income$37.8M
Non-Controlling Interests$0.00

Balance Sheet

Jun 30, 2026
Cash & Equivalents$136.0M
Accounts Receivable$138.2M
Inventory$239.3M
Current Assets$528.2M
LT Investments$0.00
Property, Plant & Equipment$72.8M
Intangibles$4.1M
Non-Current Assets$156.0M
Total Assets$684.2M
Accounts Payable$31.7M
Current Debt$4.9M
Current Liabilities$75.8M
LT Debt$192.8M
Non-Current Liabilities$200.2M
Total Liabilities$276.0M
Total Debt$197.8M
Retained Earnings-$78.5M
Shareholder Equity$408.2M
Shares Outstanding231,772,715

Cash Flow Statement

Jun 30, 2026
Operating Cash Flow$29.5M
Investing Cash Flow-$2.3M
Financing Cash Flow-$29.4M
CapEx-$2.3M
Free Cash Flow$27.3M
Depreciation & Amort.$1.8M
Stock-Based Comp$6.1M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid-$469.0K
Equity Issued/Repaid-$25.0M
Dividends Paid$0.00
Net Change in Cash-$2.1M
Data cached · Meta live · Daily live · Statements live · TTL 24h